Challenges in drug development for children
Adamson, P.C.
Clinical Advances in Hematology and Oncology H&o 15(1): 26-29
2017
ISSN/ISBN: 1543-0790 PMID: 28212366 Document Number: 694678
Document emailed within 1 workday
Related Documents
Dumont, F.J. 2002: Overview: transplantation tolerance--challenges and opportunities for drug development Current Opinion in Investigational Drugs 3(10): 1453-1457Lagutina, L.E.; Solov'eva, V.I.; Maneshina, O.A.; Kubalik, N.V. 1985: Drug allergy and the development of nephropathies in children Pediatriia 4: 41
Whitehouse, P.J.; Sciulli, C.G.; Mason, R.M. 1997: Dementia drug development: use of information systems to harmonize global drug development Psychopharmacology Bulletin 33(1): 129-133
Thirstrup, S.; Heisterberg, J. 2008: Children on the drug development map. The Danish Society of Clinical Pharmacology Ugeskrift for laeger 170(12): 1039
Kelloff, G.J.; Crowell, J.A.; Boone, C.W.; Steele, V.E.; Lubet, R.A.; Greenwald, P.; Alberts, D.S.; Covey, J.M.; Doody, L.A.; Knapp, G.G. 1994: Strategy and planning for chemopreventive drug development: clinical development plans. Chemoprevention Branch and Agent Development Committee. National Cancer Institute Journal of Cellular Biochemistry. Supplement 20: 55-62
Wijayanti, F.; Tarmizi, S.Nadia.; Tobing, V.; Nisa, T.; Akhtar, M.; Trihandini, I.; Djuwita, R. 2016: From the Millennium Development Goals to Sustainable Development Goals.: The response to the HIV epidemic in Indonesia: challenges and opportunities Journal of Virus Eradication 2(Suppl. 4): 27-31
Taylor, B.S.; Hunt, G.; Abrams, E.J.; Coovadia, A.; Meyers, T.; Sherman, G.; Strehlau, R.; Morris, L.; Kuhn, L. 2011: Rapid development of antiretroviral drug resistance mutations in HIV-infected children less than two years of age initiating protease inhibitor-based therapy in South Africa AIDS research and human retroviruses 27(9): 945-956
Satcher, D. 2001: From The Surgeon General. Sharing an agenda for children: Progress and challenges related to the 1990 World Summit for Children goals JAMA 286(11): 1305
Satcher, D. 2001: From The Surgeon General. Sharing an agenda for children: Progress and challenges related to the 1990 World Summit for Children goals JAMA 286(11): 1305
Satcher, D. 2001: From The Surgeon General. Sharing an agenda for children: Progress and challenges related to the 1990 World Summit for Children goals JAMA 286(11): 1305
Satcher, D. 2001: From The Surgeon General. Sharing an agenda for children: Progress and challenges related to the 1990 World Summit for Children goals JAMA 286(11): 1305
Jain, K.K. 2006: Challenges of drug discovery for personalized medicine Current Opinion in Molecular Therapeutics 8(6): 487-492
Goldsmith, C.H. 1991: Challenges in designing antirheumatic drug trials Journal of Rheumatology 18(11): 1643-1644
Schroeder, B.; Omar, H.A.; Swedler, J.; Hillard, P.J.A. 2002: Challenges in pubertal development Journal of Pediatric and Adolescent Gynecology 15(4): 245-250
Seth, S.D.; Sharma, B.; Bano, R.; Ganguly, N.K. 2006: Microbicide development: new challenges Indian Journal of Medical Research 123(6): 719-722
Rabøl, R.; Kampmann, J.Peter.; Christensen, H.R. 2004: Drug committees in Denmark. Status and future challenges Ugeskrift for Laeger 166(35): 2988-2991
Gruchalla, R.S. 1997: Antibiotic drug allergy: challenges of diagnosis and treatment Arbeiten aus dem Paul-Ehrlich-Institut Zu Frankfurt A.M 91: 237-249
Alhenc-Gelas, Fçois.; Parmentier, L.; Bisagni, A. 2003: Pharmacogenetic and pharmacogenomic studies. Impact on drug discovery and drug development Therapie 58(3): 275-282
Kutter, E.; Austel, V. 1981: Application of the theory of sets to drug design. Development of a new cardiotonic drug AR-L 115 BS Arzneimittel-Forschung 31(1a): 135-141
Thomas, J.W. 1995: AHi perspectives: flexible drug labeling and its impact on the drug development process. Liability issues Journal of the American Veterinary Medical Association 207(7): 899-900; Discussion: 902-904